Skip to main content
SpringerLink
Log in

Steroids for Scars

  • Chapter
  • First Online:
Total Scar Management

  • 1422 Accesses

Abstract

Steroid administration is a popular adjunct to scar management with numerous reports in the literature appraising this modality in hypertrophic and keloid scars. A variety of administration modes have been described, including injectable, ointment and transdermal (tape) forms. The most popular and extensively studied modality at present is the intralesional injection of corticosteroids with recent trends in international management protocols advocating the combined administration with other modalities, including chemotherapeutic agents and lasers. The aim of this chapter is to review the literature regarding the different modalities of steroid administration as well as the pertinent evidence base in the management of hypertrophic and keloid scars.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Behrman HT, Goodman JJ. Skin complications of cortisone and ACTH therapy. JAMA. 1950;144(3):218–21.

    Article  CAS  Google Scholar 

  2. Baker BL, Whitaker WL. Interference with wound healing by the local action of adrenocortical steroids. Endocrinology. 1950;46(6):544–51.

    Article  CAS  PubMed  Google Scholar 

  3. Polson JS, et al. Keloid. Can Med Assoc J. 1951;65(5):447–9.

    CAS  PubMed  PubMed Central  Google Scholar 

  4. Conway H, Stark RB. ACTH in plastic surgery. Plast Reconstr Surg (1946). 1951;8(5):354–77.

    Article  CAS  Google Scholar 

  5. Goldman L, Thompson RG, Trice ER. Cortisone acetate in skin disease; local effect in the skin from topical application and local injection. AMA Arch Derm Syphilol. 1952;65(2):177–86.

    Article  CAS  PubMed  Google Scholar 

  6. Coste F, Piguet B, Civitte J, Degos R, Vial-Weissenbach V, Grupper C. Traitement de Chelloides par Injections Locales d’Hydrocortisone. Trans Soc Franc de Derm et de Syph Presse med. 1953;61:1157.

    Google Scholar 

  7. De Kleine EH. Observations on the effect of cortisone on wound healing and scar formation. Plast Reconstr Surg. 1954;88:429.

    Google Scholar 

  8. Hollander A. Intralesional injections of triamcinolone acetonide; a therapy for dermatoses. Antibiotic Med Clin Ther (New York). 1961;8:78–83.

    CAS  Google Scholar 

  9. Murray RD. Kenalog and the treatment of hypertrophied scars and keloids in Negroes and whites. Plast Reconstr Surg. 1963;31:275–80.

    Article  CAS  PubMed  Google Scholar 

  10. Maguire HC Jr. Treatment of keloids with triamcinolone acetonide injected intralesionally. JAMA. 1965;192:325–6.

    Article  PubMed  Google Scholar 

  11. Griffith BH. The treatment of keloids with triamcinolone acetonide. Plast Reconstr Surg. 1966;38(3):202–8.

    Article  CAS  PubMed  Google Scholar 

  12. Minkowitz F. Regression of massive keloid following partial excision and post-operative intralesional administration of triamcinolone. Br J Plast Surg. 1967;20(4):432–5.

    Article  CAS  PubMed  Google Scholar 

  13. Jalali M, Bayat A. Current use of steroids in management of abnormal raised skin scars. Surgeon. 2007;5(3):175–80.

    Article  CAS  PubMed  Google Scholar 

  14. McMaster A, Ray DW. Drug insight: selective agonists and antagonists of the glucocorticoid receptor. Nat Clin Pract Endocrinol Metab. 2008;4(2):91–101.

    Article  CAS  PubMed  Google Scholar 

  15. Kang N, Sivakumar B, Sanders R, Nduka C, Gault D. Intra-lesional injections of collagenase are ineffective in the treatment of keloid and hypertrophic scars. J Plast Reconstr Aesthet Surg. 2006;59(7):693–9.

    Article  PubMed  Google Scholar 

  16. McCoy BJ, Diegelmann RF, Cohen IK. In vitro inhibition of cell growth, collagen synthesis, and prolyl hydroxylase activity by triamcinolone acetonide. Proc Soc Exp Biol Med. 1980;163(2):216–22.

    Article  CAS  PubMed  Google Scholar 

  17. Ogawa R. Keloid and hypertrophic scars are the result of chronic inflammation in the reticular dermis. Int J Mol Sci. 2017;18(3):E606.

    Article  PubMed  Google Scholar 

  18. Lawrence WT. In search of the optimal treatment of keloids: report of a series and a review of the literature. Ann Plast Surg. 1991;27(2):164–78.

    Article  CAS  PubMed  Google Scholar 

  19. Doggrell SA. Triamcinolone: new and old indications. Expert Opin Pharmacother. 2001;2(7):1177–86.

    Article  CAS  PubMed  Google Scholar 

  20. Lucky AW. Principles of the use of glucocorticosteroids in the growing child. Pediatr Dermatol. 1984;1:226–35.

    Article  CAS  PubMed  Google Scholar 

  21. Grumbine N, Dobrowolski C, Bernstein A. Retrospective evaluation of postoperative intralesional steroid injections on wound healing. J Foot Ankle Surg. 1998;37(2):135–44. discussion 74.

    Article  CAS  PubMed  Google Scholar 

  22. Brissett AE, Sherris DA. Scar contractures, hypertrophic scars, and keloids. Facial Plast Surg. 2001;17(4):263–72.

    Article  CAS  PubMed  Google Scholar 

  23. Kill J. Kleoids treated with topical injections of triamcinolone acetonide (Kenalog). Scand J Plast Reconsrt Surg. 1977;11:169–72.

    Google Scholar 

  24. Fredman R, Tenenhaus M. Cushing’s syndrome after intralesional triamcinolone acetonide: a systematic review of the literature and multinational survey. Burns. 2013;39(4):549–57.

    Article  PubMed  Google Scholar 

  25. Darzi MA, Chowdri NA, Kaul SK, Khan M. Evaluation of various methods of treating keloids and hypertrophic scars: a 10-year follow-up study. Br J Plast Surg. 1992;45(5):374–9.

    Article  CAS  PubMed  Google Scholar 

  26. Ogawa R, Akaishi S, Kuribayashi S, Miyashita T. Keloids and hypertrophic scars can now be cured completely: recent progress in our understanding of the pathogenesis of keloids and hypertrophic scars and the most promising current therapeutic strategy. J Nippon Med Sch. 2016;83(2):46–53.

    Article  CAS  PubMed  Google Scholar 

  27. Mustoe TA, Cooter RD, Gold MH, Hobbs FD, Ramelet AA, Shakespeare PG, et al. International clinical recommendations on scar management. Plast Reconstr Surg. 2002;110(2):560–71.

    Article  PubMed  Google Scholar 

  28. Ardehali B, Nouraei SA, Van Dam H, Dex E, Wood S, Nduka C. Objective assessment of keloid scars with three-dimensional imaging: quantifying response to intralesional steroid therapy. Plast Reconstr Surg. 2007;119(2):556–61.

    Article  CAS  PubMed  Google Scholar 

  29. Kelly AP. Update on the management of keloids. Semin Cutan Med Surg. 2009;28(2):71–6.

    Article  CAS  PubMed  Google Scholar 

  30. Rutkowski D, Syed F, Matthews LC, Ray DW, McGrouther DA, Watson RE, et al. An abnormality in glucocorticoid receptor expression differentiates steroid responders from nonresponders in keloid disease. Br J Dermatol. 2015;173(3):690–700.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Gupta S, Sharma VK. Standard guidelines of care: keloids and hypertrophic scars. Indian J Dermatol Venereol Leprol. 2011;77(1):94–100.

    Article  PubMed  Google Scholar 

  32. Mandal A, Imran D. Painless steroid injections for hypertrophic scars and keloids. Br J Plast Surg. 2003;56(1):79.

    Article  PubMed  Google Scholar 

  33. Vallis CP. Intralesional injection of keloids and hypertrophic scars with the Dermo-Jet. Plast Reconstr Surg. 1967;40(3):255–62.

    Article  CAS  PubMed  Google Scholar 

  34. Ono N. Pain-free intralesional injection of triamcinolone for the treatment of keloid. Scand J Plast Reconstr Surg Hand Surg. 1999;33(1):89–91.

    Article  CAS  PubMed  Google Scholar 

  35. Ceilley RI, Babin RW. The combined use of cryosurgery and intralesional injections of suspensions of fluorinated adrenocorticosteroids for reducing keloids and hypertrophic scars. J Dermatol Surg Oncol. 1979;5(1):54–6.

    Article  CAS  PubMed  Google Scholar 

  36. Zuber TJ, DeWitt DE. Earlobe keloids. Am Fam Physician. 1994;49(8):1835–41.

    CAS  PubMed  Google Scholar 

  37. Muneuchi G, Suzuki S, Onodera M, Ito O, Hata Y, Igawa HH. Long-term outcome of intralesional injection of triamcinolone acetonide for the treatment of keloid scars in Asian patients. Scand J Plast Reconstr Surg Hand Surg. 2006;40(2):111–6.

    Article  PubMed  Google Scholar 

  38. Boyadjiev C, Popchristova E, Mazgalova J. Histomorphologic changes in keloids treated with Kenacort. J Trauma. 1995;38(2):299–302.

    Article  CAS  PubMed  Google Scholar 

  39. Brown LA Jr, Pierce HE. Keloids: scar revision. J Dermatol Surg Oncol. 1986;12(1):51–6.

    Article  PubMed  Google Scholar 

  40. Barton RP. Auricular keloids: a simple method of management. Ann R Coll Surg Engl. 1978;60(4):324–5.

    CAS  PubMed  PubMed Central  Google Scholar 

  41. Donkor P. Head and neck keloid: treatment by core excision and delayed intralesional injection of steroid. J Oral Maxillofac Surg. 2007;65(7):1292–6.

    Article  PubMed  Google Scholar 

  42. Tang YW. Intra- and postoperative steroid injections for keloids and hypertrophic scars. Br J Plast Surg. 1992;45(5):371–3.

    Article  CAS  PubMed  Google Scholar 

  43. Golladay ES. Treatment of keloids by single intraoperative perilesional injection of repository steroid. South Med J. 1988;81(6):736–8.

    Article  CAS  PubMed  Google Scholar 

  44. Tripoli M, Cordova A, Melloni C, Zabbia G, Maggì F, Moschella F. The use of triamcinolone combined with surgery in major ear keloid treatment: a personal two stages approach. Eur J Plast Surg. 2015;38(3):205–10.

    Article  Google Scholar 

  45. Chowdri NA, Masarat M, Mattoo A, Darzi MA. Keloids and hypertrophic scars: results with intraoperative and serial postoperative corticosteroid injection therapy. Aust N Z J Surg. 1999;69(9):655–9.

    Article  CAS  PubMed  Google Scholar 

  46. Park TH, Seo SW, Kim JK, Chang CH. Clinical characteristics of facial keloids treated with surgical excision followed by intra- and postoperative intralesional steroid injections. Aesthetic Plast Surg. 2012;36(1):169–73.

    Article  PubMed  Google Scholar 

  47. Rosen DJ, Patel MK, Freeman K, Weiss PR. A primary protocol for the management of ear keloids: results of excision combined with intraoperative and postoperative steroid injections. Plast Reconstr Surg. 2007;120(5):1395–400.

    Article  CAS  PubMed  Google Scholar 

  48. Moustafa MFH, Abdel-Fattah AMA. Keloids of the ear lobes in Egypt: their rarity in childhood and their treatment. Br J Plast Surg. 1976;29:59.

    Article  CAS  PubMed  Google Scholar 

  49. Kauh YC, Rouda S, Mondragon G, Tokarek R, di Leonardo M, Tuan RS, et al. Major suppression of pro-alpha1(I) type I collagen gene expression in the dermis after keloid excision and immediate intrawound injection of triamcinolone acetonide. J Am Acad Dermatol. 1997;37(4):586–9.

    Article  CAS  PubMed  Google Scholar 

  50. Sproat JE, Dalcin A, Weitauer N, Roberts RS. Hypertrophic sternal scars: silicone gel sheet versus Kenalog injection treatment. Plast Reconstr Surg. 1992;90(6):988–92.

    Article  CAS  PubMed  Google Scholar 

  51. Al-Attar A, Mess S, Thomassen JM, Kauffman CL, Davison SP. Keloid pathogenesis and treatment. Plast Reconstr Surg. 2006;117(1):286–300.

    Article  CAS  PubMed  Google Scholar 

  52. Murray JC. Scars and keloids. Dermatol Clin. 1993;11(4):697–708.

    Article  CAS  PubMed  Google Scholar 

  53. Ledon JA, Savas J, Franca K, Chacon A, Nouri K. Intralesional treatment for keloids and hypertrophic scars: a review. Dermatol Surg. 2013;39(12):1745–57.

    Article  CAS  PubMed  Google Scholar 

  54. Shaffer JJ, Taylor SC, Cook-Bolden F. Keloidal scars: a review with a critical look at therapeutic options. J Am Acad Dermatol. 2002;46(2 Suppl Understanding):S63–97.

    Article  PubMed  Google Scholar 

  55. Jemec GB. Linear atrophy following intralesional steroid injections. J Dermatol Surg Oncol. 1988;14(1):88–9.

    Article  CAS  PubMed  Google Scholar 

  56. Mollmann H, Rohdewald P, Schmidt EW, Salomon V, Derendorf H. Pharmacokinetics of triamcinolone acetonide and its phosphate ester. Eur J Clin Pharmacol. 1985;29:85–9.

    Article  CAS  PubMed  Google Scholar 

  57. Meikle AW, Clarke DH, Tyler FH. Cushing syndrome form low doses of dexamethasone a result of slow plasma clearance. JAMA. 1976;235:1592–3.

    Article  CAS  PubMed  Google Scholar 

  58. Ross EJ, Linch DC. Cushing’s syndrome—killing disease: discriminatory value of signs and symptoms aiding early diagnosis. Lancet (London, England). 1982;2(8299):646–9.

    Article  CAS  Google Scholar 

  59. Marsden CW. Fluocinolone acetonide 0.25 cream-a co-operative clinical trial. Br J Dermatol. 1968;80:614–7.

    Article  CAS  PubMed  Google Scholar 

  60. Yi NW, Frame JD. Evaluation of cynthaskin and topical steroid in the treatment of hypertrophic scars and keloids. Eur J Plast Surg. 1996;19:162–5.

    Google Scholar 

  61. Hayashi T, Furukawa H, Oyama A, Funayama E, Saito A, Murao N, Yamamoto Y. A new uniform protocol of combined corticosteroid injections and ointment application reduces recurrence rates after surgical keloid/hypertrophic scar excision. Dermatol Surg. 2012;38:893–7.

    Article  CAS  PubMed  Google Scholar 

  62. Goldman L, Igelman JM, Kitzmiller KW. Clinical investigative studies with flurandrenolone tape. Cutis. 1967;3:367–71.

    Google Scholar 

  63. Rauscher GE, Kolmer WL. Treatment of recurrent earlobe keloids. Cutis. 1986;37:67–8.

    CAS  PubMed  Google Scholar 

  64. Tillman WJ, Higuchi T. Quantitative evaluation of the interaction of callus strips with some hydroxylic solvents. J Invest Dermatol. 1961;27:87.

    Article  Google Scholar 

  65. Frank L, Rapp Y. Occlusive topical corticosteroids and heat in psoriasis. Arch Dermatol. 1963;87:32.

    Article  CAS  PubMed  Google Scholar 

  66. Riley K. Flurandrenolone (Cordran) tape as occlusive therapy. JSC Med Assoc. 1969;65:171–2.

    CAS  Google Scholar 

  67. Fisher LB, Maibach HI, Trancik RJ. Effects of occlusive tape systems on the mitotic activity of epidermis with and without corticosteroids. Arch Dermatol. 1978;114:384–6.

    Article  CAS  PubMed  Google Scholar 

  68. Widgerow AD, Chait LA, Stals R, et al. New innovations in scar management. Aesthetic Plast Surg. 2000;24:227–34.

    Article  CAS  PubMed  Google Scholar 

  69. Goutos I, Ogawa R. Steroid tape: a promising adjunct to scar management. Scars, Burn Heal. 2017;3:2059513117690937.

    Google Scholar 

  70. Huang C, Akaishi S, Hyakusoku H, Ogawa R. Are keloid and hypertrophic scar different forms of the same disorder? A fibroproliferative skin disorder hypothesis based on keloid findings. Int Wound J. 2014;11(5):517–22.

    Article  PubMed  Google Scholar 

  71. Huang C, Murphy GF, Akaishi S, Ogawa R. Keloids and hypertrophic scars: update and future directions. Plast Reconstr Surg Glob Open. 2013;1(4):e25.

    Article  PubMed  PubMed Central  Google Scholar 

  72. Goldblatt S. The use of Cordran tape in dermatology. Ohio State Med J. 1969;65(11):1118–21.

    CAS  PubMed  Google Scholar 

  73. Ratzer MA. A clinical trial of flurandrenolone tape. Br J Clin Pract. 1970;24:185–9.

    CAS  PubMed  Google Scholar 

  74. DP Study Group. Analysis of clinical outcomes of deprodone propionate plaster for various skin diseases. Rinsholyaku. 1989;5:2177–85. (in Japanese).

    Google Scholar 

  75. Labow TA, Eisert J, Sanders SL. Flurandrenolide tape in the treatment of psoriasis. NY State J Med. 1969;69:3138–40.

    CAS  Google Scholar 

  76. Kim S, Choi TH, Liu W, Ogawa R, Suh JS, Mustoe TA. Update on scar management: guidelines for treating Asian patients. Plast Reconstr Surg. 2013;132:1580.

    Article  CAS  PubMed  Google Scholar 

  77. Gold MH, Berman B, Clementoni MT, Gauglitz GG, Nahai F, Murcia C. Updated international clinical recommendations on scar management: part 1—evaluating the evidence. Dermatol Surg. 2014;40(8):817–24.

    CAS  PubMed  Google Scholar 

  78. Gold MH, McGuire M, Mustoe TA, Pusic A, Sachdev M, Waibel J, et al. Updated international clinical recommendations on scar management: part 2—algorithms for scar prevention and treatment. Dermatol Surg. 2014;40(8):825–31.

    CAS  PubMed  Google Scholar 

  79. Meaume S, Le Pillouer-Prost A, Richert B, Roseeuw D, Vadoud J. Management of scars: updated practical guidelines and use of silicones. Eur J Dermatol. 2014;24(4):435–43.

    PubMed  Google Scholar 

  80. Sclafani AP, Gordon L, Chadha M, Romo T 3rd. Prevention of earlobe keloid recurrence with postoperative corticosteroid injections versus radiation therapy: a randomized, prospective study and review of the literature. Dermatol Surg. 1996;22(6):569–74.

    Article  CAS  PubMed  Google Scholar 

  81. Layton AM, Yip J, Cunliffe WJ. A comparison of intralesional triamcinolone and cryosurgery in the treatment of acne keloids. Br J Dermatol. 1994;130:498–501.

    Article  CAS  PubMed  Google Scholar 

  82. Shah VV, Aldahan AS, Mlacker S, Alsaidan M, Samarkendy S, Nouri K. 5_Fluorouracil in the treatment of keloids and hypertrophic scars: a comprehensive review of the literature. Dermatol Ther. 2016;6:169–83.

    Article  Google Scholar 

  83. Saha AK, Mukhopadhyay M. A comparative clinical study on role of 5-fluorouracil versus triamcinolone in the treatment of keloids. Indian J Surg. 2012;74(4):326–9.

    Article  PubMed  PubMed Central  Google Scholar 

  84. Prabhu A, et al. A randomized controlled trial comparing the efficacy of intralesional 5-fluorouracil versus triamcinolone acetonide in the treatment of keloids. J Sci Soc. 2012;39(1):19.

    Google Scholar 

  85. Khan MA, Bashir MM, Khan FA. Intralesional triamcinolone alone and in combination with 5-fluorouracil for the treatment of keloid and hypertrophic scars. J Pak Med Assoc. 2014;64(9):1003–7.

    PubMed  Google Scholar 

  86. Darougheh A, Asilian A, Shariati F. Intralesional triamcinolone alone or in combination with 5-fluorouracil for the treatment of keloid and hypertrophic scars. Clin Exp Dermatol. 2009;34(2):219–23.

    Article  CAS  PubMed  Google Scholar 

  87. Davison SP, Dayan JH, Clemens MW, Sonni S, Wang A, Crane A. Efficacy of intralesional 5-fluorouracil and triamcinolone in the treatment of keloids. Aesthet Surg J. 2009;29:40–6.

    Article  PubMed  Google Scholar 

  88. Manuskiatti W, Fitzpatrick RE. Treatment response of keloidal and hypertrophic sternotomy scars: comparison among intralesional corticosteroid, 5-fluorouracil, and 585 nm flashlamp-pumped pulsed-dye laser treatments. Arch Dermatol. 2002;138:1149–55.

    Article  CAS  PubMed  Google Scholar 

  89. Asilian A, Darougheh A, Shariati F. New combination of triamcinolone, 5-Fluorouracil, and pulsed-dye laser for treatment of keloid and hypertrophic scars. Dermatol Surg. 2006;32(7):907–15.

    CAS  PubMed  Google Scholar 

  90. Alster T. Laser scar revision: comparison study of 585-nm pulsed dye laser with and without intralesional corticosteroids. Dermatol Surg. 2003;29:25–9.

    PubMed  Google Scholar 

  91. Waibel JS, Wulkan AJ, Shumaker PR. Treatment of hypertrophic scars using laser and laser assisted corticosteroid delivery. Lasers Surg Med. 2013;45(3):135–40.

    Article  PubMed  Google Scholar 

  92. Martin MS, Collawn SS. Combination treatment of CO2 fractional laser, pulse dye laser and triamcinolone acetonide injection for refractory keloid scars on the upper back. J Cosmet Laser Ther. 2013;15(3):166–70.

    Article  PubMed  Google Scholar 

  93. Son IP, Park KY, Kim B, et al. Pilot study of the efficacy of 578 nm copper bromide corporate laser combined with intralesional corticosteroid injection for treatment of keloids and hypertrophic scars. Ann Dermatol. 2014;26:156–61.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

I would like to acknowledge Dr. Osaid Alser and Miss Ruthann Fanstone for their helpful contributions and input into this piece of work.

Author information

Authors and Affiliations

  1. Royal London Hospital, Barts Health NHS Trust, Whitechapel, UK

    Ioannis Goutos

  2. Centre for Cutaneous Research, Blizard Institute, Queen Mary University of London, London, UK

    Ioannis Goutos

Authors
  1. Ioannis Goutos
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ioannis Goutos .

Editor information

Editors and Affiliations

  1. Department of Plastic, Reconstructive and Aesthetic Surgery, Nippon Medical School, Tokyo, Japan

    Rei Ogawa

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Goutos, I. (2020). Steroids for Scars. In: Ogawa, R. (eds) Total Scar Management. Springer, Singapore. https://doi.org/10.1007/978-981-32-9791-3_12

Download citation

  • DOI: https://doi.org/10.1007/978-981-32-9791-3_12

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-32-9790-6

  • Online ISBN: 978-981-32-9791-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation